CNBC's Jim Cramer on Thursday explained four different schools of thought in examining the mixed messages they took from Wednesday's Federal Reserve meeting.
Cramer noted that the first camp of buyers believe the Fed's bark is worse than its bite and don't think it will end up hiking rates to the point of recession.
These buyers, according to Cramer, are investing in industrial companies that do well in a bustling economy.
Cramer believes these buyers would be wise to invest in Big Pharma because the industry is "more or less recession-proof."
"When you put these four, often contradictory, groups of buyers together, you can get a magnificent run across the board like we had today," Cramer said.
Persons:
CNBC's Jim Cramer, Cramer, Eli Lilly, Johnson
Organizations:
Wednesday's Federal, Fed, Big Pharma
Locations:
Cava